Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R&D Outsourcing Could Make China, India Pharma Giants

This article was originally published in PharmAsia News

Executive Summary

The practice of multinational pharmaceuticals of outsourcing research and development is helping to build China and India into major producers of intellectual property products as they develop novel drugs. The author of a study on the impact of R&D in China and India said the two countries are rapidly developing scientists with the ability to innovate in the pharma field, faster than would have been imagined five years ago. Because most risk-sharing agreements with foreign drug makers are less than four years old, concrete results from all the work may not be known for another decade, he said, given the time required to bring a drug to market. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070891

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel